Woodline Partners LP

Holdings History for PLIANT THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (PLRX)

Symbol: PLRX on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share
Latest Disclosed Shares Owned: 2,026,191 shares
Security Ownership %: 3.3%

Shares, Excluding Options vs Price

Value, Excluding Options

Woodline Partners LP ownership in PLIANT THERAPEUTICS, INC. Common Stock, par value $0.0001 per share (PLRX)

17 Feb 2026 - Woodline Partners LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 2,026,191 shares of PLIANT THERAPEUTICS, INC. Common Stock, par value $0.0001 per share (PLRX). This represents 3.3% ownership of the company. In their previous filing dated 14 Nov 2025, Woodline Partners LP had reported owning 4,504,817 shares, indicating a decrease of +55%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Woodline Partners LP	3.3%	-57%	$2,471,953	2,026,191	-2,478,626	-55%	$1.22	13G/A	31 Dec 2025	17 Feb 2026, 15:21
Woodline Partners LP	7.3%		$6,667,129	4,504,817			$1.48	13G	30 Sep 2025	14 Nov 2025, 16:17

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.01%	-0.01%	$2,471,953	2,026,191	-2,478,626	-55%	$1.22	Q4 2025
30 Sep 2025	0.03%	+0.02%	$6,667,129	4,504,817	+2,156,291	+92%	$1.48	Q3 2025
30 Jun 2025	0.01%	-0%	$2,724,290	2,348,526	-165,558	-6.6%	$1.16	Q2 2025
31 Mar 2025	0.02%	+0.02%	$3,394,013	2,514,084	+2,386,789	+1800%	$1.35	Q1 2025
31 Dec 2024	0.01%	+0%	$1,676,475	127,295	+15,635	+14%	$13.17	Q4 2024
30 Sep 2024	0.01%	+0%	$1,251,709	111,660	+8,037	+7.8%	$11.21	Q3 2024
30 Jun 2024	0.01%	+0%	$1,113,947	103,623	+3,480	+3.5%	$10.75	Q2 2024
31 Mar 2024	0.01%	-0%	$1,492,131	100,143	-23,947	-19%	$14.90	Q1 2024
31 Dec 2023	0.02%	-0.06%	$2,247,270	124,090	-312,162	-72%	$18.11	Q4 2023
30 Sep 2023	0.09%	+0.04%	$7,564,610	436,252	+178,754	+69%	$17.34	Q3 2023
30 Jun 2023	0.06%	+0.06%	$4,665,864	257,498	+257,498	NEW	$18.12	Q2 2023
31 Dec 2021		-0.05%	$0	0	-179,993	-100%	$1.22	Q4 2021
30 Sep 2021	0.05%	+0.03%	$3,038,000	179,993	+108,330	+151%	$16.88	Q3 2021
30 Jun 2021	0.04%	+0.04%	$2,087,000	71,663	+71,663	NEW	$29.12	Q2 2021
31 Dec 2020		-0.11%	$0	0	-152,000	-100%	$1.22	Q4 2020
30 Sep 2020	0.11%	+0.11%	$3,443,000	152,000	+152,000	NEW	$22.65	Q3 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.